Jakob Lovén

4.2k total citations · 1 hit paper
17 papers, 3.1k citations indexed

About

Jakob Lovén is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Jakob Lovén has authored 17 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Neurology. Recurrent topics in Jakob Lovén's work include Protein Degradation and Inhibitors (5 papers), Genomics and Chromatin Dynamics (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jakob Lovén is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Genomics and Chromatin Dynamics (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jakob Lovén collaborates with scholars based in United States, Sweden and Canada. Jakob Lovén's co-authors include Richard A. Young, Tong Ihn Lee, Peter B. Rahl, Christopher B. Burge, James E. Bradner, Charles Y. Lin, Ronald M. Paranal, David A. Orlando, Matthew G. Guenther and Alla A. Sigova and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Jakob Lovén

17 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional Amplification in Tumor Cells with Elevated c-Myc

2012 1.1k citations Charles Y. Lin, Jakob Lovén et al. Cell profile →

Peers

Jakob Lovén

ONCOL

GENET

IMMUN

Pierre de la Grange France

Ashley Lau United States

Tilman Borggrefe Germany

Warren A. Whyte United States

Benjamin A. Garcia United States

Luciana Chessa Italy

Behnam Nabet United States

Howard H. Yang United States

Jasper Mullenders Netherlands

Xiaole Shirley Liu United States

Pierre de la Grange France

Jakob Lovén

2.2k ×0.9

630 ×1.0

462 ×1.1

ONCOL

273 ×0.7

GENET

333 ×1.4

IMMUN

Citations per year, relative to Jakob Lovén Jakob Lovén (= 1×) peers Pierre de la Grange

Countries citing papers authored by Jakob Lovén

Since Specialization

Citations

This map shows the geographic impact of Jakob Lovén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Lovén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Lovén more than expected).

Fields of papers citing papers by Jakob Lovén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Lovén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Lovén. The network helps show where Jakob Lovén may publish in the future.

Co-authorship network of co-authors of Jakob Lovén

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Lovén. A scholar is included among the top collaborators of Jakob Lovén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Lovén. Jakob Lovén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

McKeown, Michael R., M. Ryan Corces, Matthew L. Eaton, et al.. (2017). Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist. Cancer Discovery. 7(10). 1136–1153. 89 indexed citations

Klarqvist, Marcus D. R., Ulrica Westermark, Ganna Oliynyk, et al.. (2016). Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients. Cell Reports. 16(4). 979–993. 20 indexed citations

Lohcharoenkal, Warangkana, Masako Harada, Jakob Lovén, et al.. (2016). MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. Journal of Investigative Dermatology. 136(12). 2485–2494. 32 indexed citations

Anders, Lars, Matthew G. Guenther, Jun Qi, et al.. (2014). Genome-wide determination of drug localization. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 137 indexed citations

Eaton, Matthew L., Nan Rosemary Ke, Christian Fritz, et al.. (2014). Discovery and Characterization of Super-Enhancer-Associated Dependencies in Acute Myeloid Leukemia. Blood. 124(21). 3539–3539. 1 indexed citations

Li, Yun, Haoyi Wang, Julien Muffat, et al.. (2013). Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons. Cell stem cell. 13(4). 446–458. 243 indexed citations

Lovén, Jakob, Heather A. Hoke, Charles Y. Lin, et al.. (2013). Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers. Cell. 153(2). 320–334. 122 indexed citations

Anders, Lars, Matthew G. Guenther, Jun Qi, et al.. (2013). Genome-wide localization of small molecules. Nature Biotechnology. 32(1). 92–96. 1 indexed citations

Lovén, Jakob, David A. Orlando, Alla A. Sigova, et al.. (2012). Revisiting Global Gene Expression Analysis. Cell. 151(3). 476–482. 414 indexed citations

10.

Sonkoly, Enikö, Jakob Lovén, Ning Xu, et al.. (2012). MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis. 1(3). e3–e3. 83 indexed citations

11.

Lin, Charles Y., Jakob Lovén, Peter B. Rahl, et al.. (2012). Transcriptional Amplification in Tumor Cells with Elevated c-Myc. Cell. 151(1). 56–67. 1119 indexed citations breakdown →

12.

Mullen, Alan C., David A. Orlando, Jamie J. Newman, et al.. (2011). Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β Signaling. Cell. 147(3). 565–576. 458 indexed citations

13.

Frenzel, Anna, et al.. (2010). Targeting MYC-Regulated miRNAs to Combat Cancer. Genes & Cancer. 1(6). 660–667. 52 indexed citations

14.

Lovén, Jakob, Inga Müller, Petter Brodin, et al.. (2010). MYCN-regulated microRNAs repress estrogen receptor-α ( ESR1 ) expression and neuronal differentiation in human neuroblastoma. Proceedings of the National Academy of Sciences. 107(4). 1553–1558. 106 indexed citations

15.

Lerner, Mikael, Masako Harada, Jakob Lovén, et al.. (2009). DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Experimental Cell Research. 315(17). 2941–2952. 132 indexed citations

16.

Lovén, Jakob, et al.. (2007). Anti-inflammatory activity of β₂-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. European Respiratory Journal. 30(5). 848–856. 27 indexed citations

17.

Albihn, Ami, et al.. (2006). c‐Myc‐dependent etoposide‐induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling. Journal of Cellular Biochemistry. 98(6). 1597–1614. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact